Literature DB >> 2210447

Effect of ulcerative colitis and smoking on rectal blood flow.

E D Srivastava1, M A Russell, C Feyerabend, J Rhodes.   

Abstract

Rectal blood flow was measured by laser doppler flowmetry over 60 minutes in eight patients with colitis in remission and eight healthy male non-smokers. Ten smokers were also examined on two occasions, one of which included smoking a cigarette. Plasma nicotine concentrations were measured in smokers. All subjects showed a pronounced fall in rectal blood flow in the first 30 minutes and patients with colitis had significantly higher values compared with smokers (p less than 0.002; p less than 0.04) and non-smokers (p less than 0.007; p less than 0.002) during the first and second 30 minutes respectively. Values in smokers and non-smokers were similar, but smoking a cigarette was associated with a significant fall in blood flow (p less than 0.04) and this change was inversely related to the rise in plasma nicotine concentration (r = -0.63; p less than 0.05). The findings may be relevant to the association between colitis and the smoking history.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210447      PMCID: PMC1378661          DOI: 10.1136/gut.31.9.1021

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Comparative vasoconstrictor effects of inhaling tobacco smoke in warm and cool environments and before and after abstinence from tobacco.

Authors:  J W ECKSTEIN; J E WOOD; R W WILKINS
Journal:  Am Heart J       Date:  1957-03       Impact factor: 4.749

2.  Assay of nicotine in biological materials: sources of contamination and their elimination.

Authors:  C Feyerabend; M A Russell
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

3.  Tissue penetration and measuring depth of laser Doppler flowmetry in the gastrointestinal application.

Authors:  K Johansson; H Ahn; J Lindhagen; O Lundgren
Journal:  Scand J Gastroenterol       Date:  1987-11       Impact factor: 2.423

4.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

5.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

6.  Late presentation of ulcerative colitis in ex-smokers.

Authors:  R J Motley; J Rhodes; S Kay; T J Morris
Journal:  Int J Colorectal Dis       Date:  1988-08       Impact factor: 2.571

7.  Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease.

Authors:  P Nicod; R Rehr; M D Winniford; W B Campbell; B G Firth; L D Hillis
Journal:  J Am Coll Cardiol       Date:  1984-11       Impact factor: 24.094

8.  Nicotine pharmacokinetics and its application to intake from smoking.

Authors:  C Feyerabend; R M Ings; M A Russel
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

9.  Assessment of gastric blood flow with laser Doppler flowmetry.

Authors:  H Ahn; L E Ivarsson; K Johansson; J Lindhagen; O Lundgren
Journal:  Scand J Gastroenterol       Date:  1988-12       Impact factor: 2.423

10.  Assessment of blood flow in the small intestine with laser Doppler flowmetry.

Authors:  H Ahn; J Lindhagen; G E Nilsson; P A Oberg; O Lundgren
Journal:  Scand J Gastroenterol       Date:  1986-09       Impact factor: 2.423

View more
  25 in total

Review 1.  Nicotine treatment for ulcerative colitis.

Authors:  M Guslandi
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  Remodeling of vascular wall in Crohn's disease.

Authors:  Y Funayama; I Sasaki; H Naito; K Fukushima; S Matsuno; T Masuda
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 3.  Role of smoking in inflammatory bowel disease: implications for therapy.

Authors:  G A Thomas; J Rhodes; J T Green; C Richardson
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

4.  Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model.

Authors:  Roma Kalra; Shashi P Singh; Juan C Pena-Philippides; Raymond J Langley; Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 5.  Cigarette smoking and intestinal defences.

Authors:  G F Cope; R V Heatley
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

6.  (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa.

Authors:  Tanja Spoettl; Christine Paetzel; Hans Herfarth; Merouane Bencherif; Juergen Schoelmerich; Roland Greinwald; Gregory J Gatto; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2006-05-20       Impact factor: 2.571

7.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.

Authors:  S A Mitchell; M Thyssen; T R Orchard; D P Jewell; K A Fleming; R W Chapman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis.

Authors:  M Guslandi; A Tittobello
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

10.  Smoking and ulcerative colitis: a community study.

Authors:  E D Srivasta; R G Newcombe; J Rhodes; P Avramidis; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.